ANGISED TABLET 0.5 mg

Riik: Singapur

keel: inglise

Allikas: HSA (Health Sciences Authority)

Toimeaine:

GLYCERYL TRINITRATE

Saadav alates:

GLAXOSMITHKLINE PTE LTD

ATC kood:

C01DA02

Annus:

0.5 mg

Ravimvorm:

TABLET

Koostis:

GLYCERYL TRINITRATE 0.5 mg

Manustamisviis:

ORAL

Retsepti tüüp:

Pharmacy Only

Valmistatud:

GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD

Volitamisolek:

ACTIVE

Loa andmise kuupäev:

1988-06-24

Infovoldik

ANGISED™  
GLYCERYL TRINITRATE 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
_ANGISED_ sublingual tablets contain
0.5 mg (500 micrograms) glyceryl trinitrate. 
PHARMACEUTICAL FORM 
Sublingual tablets. 
CLINICAL PARTICULARS 
INDICATIONS 
_ANGISED_ is indicated
for the treatment of acute attacks of angina pectoris including 
variant angina and for the prophylaxis of such attacks. 
_ANGISED_ may be used
for the emergency treatment of pulmonary oedema. 
DOSAGE AND ADMINISTRATION 
_ANGISED_ must be placed under the tongue (administered
sublingually) and retained in 
the mouth until dissolved or discarded.  
TREATMENT OF ACUTE ATTACKS ANGINA PECTORIS 
When angina starts, one tablet should be taken every 3
minutes until cessation of pain or 
limiting side effects, such
as headache or light-headedness supervene. The patient should 
preferably rest in the sitting position because of the risk
of symptomatic postural 
hypotension. 
PROPHYLAXIS OF ANGINA PECTORIS 
_ANGISED _one tablet may be used prior to activity which
is likely to precipitate angina 
pectoris. 
TREATMENT OF PULMONARY OEDEMA 
In the treatment of pulmonary oedema doses ranging between
0.8 mg and 2.4 mg of 
_ANGISED_ has been used at intervals of 5 to 10 minutes. 
  CHILDREN 
No data are available on the use of _ANGISED_ in children. 
  ELDERLY 
Hypotension and syncope can be a particular problem with
use of nitrates in the elderly.  
Patients should be advised to sit down whenever possible when
taking sublingual 
_ANGISED_. 
CONTRAINDICATIONS 
_ANGISED_ is contraindicated in angina caused
by hypertrophic obstructive 
cardiomyopathy as it may exaggerate outflow obstruction. 
_ANGISED_ should not be used in patients with possible increased
intracranial pressure 
(e.g. cerebral haemorrhage or head trauma). 
_ANGISED_ is contraindicated in
patients taking phosphodi

Toote omadused

ANGISED™
GLYCERYL TRINITRATE
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ANGISED_
sublingual tablets contain 0.5 mg (500 micrograms) glyceryl
trinitrate.
PHARMACEUTICAL FORM
Sublingual tablets.
CLINICAL PARTICULARS
INDICATIONS
_ANGISED_
is indicated for the treatment of acute attacks of angina pectoris
including
variant angina and for the prophylaxis of such attacks.
_ANGISED_
may be used for the emergency treatment of pulmonary oedema.
DOSAGE AND ADMINISTRATION
_ANGISED_
must be placed under the tongue (administered sublingually) and
retained in
the mouth until dissolved or discarded.
TREATMENT OF ACUTE ATTACKS ANGINA PECTORIS
When angina starts, one tablet should be taken every 3 minutes until
cessation of pain or
limiting side effects, such as headache or light-headedness supervene.
The patient should
preferably rest in the sitting position because of the risk of
symptomatic postural
hypotension.
PROPHYLAXIS OF ANGINA PECTORIS
_ANGISED _
one tablet may be used prior to activity which is likely to
precipitate angina
pectoris.
TREATMENT OF PULMONARY OEDEMA
In the treatment of pulmonary oedema doses ranging between 0.8 mg and
2.4 mg of
_ANGISED_
has been used at intervals of 5 to 10 minutes.

CHILDREN
No data are available on the use of
_ANGISED_
in children.

ELDERLY
Hypotension and syncope can be a particular problem with use of
nitrates in the elderly.
Patients should be advised to sit down whenever possible when taking
sublingual
_ANGISED_
.
CONTRAINDICATIONS
_ANGISED_
is contraindicated in angina caused by hypertrophic obstructive
cardiomyopathy as it may exaggerate outflow obstruction.
_ANGISED_
should not be used in patients with possible increased intracranial
pressure
(e.g. cerebral haemorrhage or head trauma).
_ANGISED_
is contraindicated in patients taking phosphodiesterase type 5
inhibitors (e.g.
sildenafil, vardenafil, tadalafil) (
_see Interactions_
).
_ANGISED_
is contraindicated in patients taking soluble guanylate cyclase (sGC)
stimulators, such as riociguat (
_see Interactions_
).
_ANGISED